Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
News
FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype
Blinatumomab has received full approval from the FDA after long-term data confirmed its safety and efficacy.
Research
Immune-Onc Therapeutics Announces IO-202 Granted Fast Track Designation by FDA for the Treatment of Relapsed or Refractory CMML
PALO ALTO, Calif., June 7, 2023 – Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage oncology company dedicated to the discovery …
News
FDA Approves New Bispecific Antibody for Non-Hodgkin Lymphoma Subtype
Epcoritamab gives patients with diffuse large B-cell lymphoma another treatment option.
News
FDA Approves Therapy to Decrease Infection Risk Following Stem Cell Transplant
“This new treatment is a big step forward that may help improve patient outcomes,” said LLS Chief Scientific Officer Lee Greenberger, Ph.D. “LLS was o…
News
FDA Approves Treatment for Patients Newly Diagnosed with Most Common Lymphoma
“The FDA’s decision gives newly diagnosed patients with this aggressive form of lymphoma their first new treatment option in nearly two decades,” says…
